IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Solid Tumor. According to GlobalData, Phase II drugs for Solid Tumor have a 38% phase transition ...
IAP-0971 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Non-Hodgkin Lymphoma. According to GlobalData, Phase II drugs for Non-Hodgkin Lymphoma have a 35 ...